ASAPHARM
ActiveASAPHARM has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €160k and a net result of €140k. Equity is growing by ~18% per year across the filed fiscal years. Its solvency ranks better than 19% of 10345 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
55
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability59▼-3
Solvency34▼-10
Growth78=
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €8k at 30 days acceptable
Liquidity short (current ratio 0.05 against 0.35 in 2024; short-term debt: 28.7% and cash: 0.4% of total assets), and 91.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
8.6%
Return on assets
7.5%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 10345 sector peers (2025).
NBB · sector comparisonPosition among 10345 sector peers
Solvency
better than 19%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
32 d early
2024
20 d early
2023
13 d early
2022
33 d early
2021
11 d early
2020
26 d late
2019
45 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€140k▲ 14.4%
2024 · €122k
2018: €16k
2019: €16k
2020: €19k
2021: €11k
2022: €-7k
2023: €109k
2024: €122k
2018 → 2025
Working capital
€-508k▼ 296%
2024 · €-128k
2018: €46k
2019: €57k
2020: €81k
2021: €92k
2022: €-128k
2023: €-173k
2024: €-128k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€94k-€46k▼ 51.5%€130k▲ 186%€252k▲ 93.6%€160k▼ 36.5%
Operating result€17k-€6k▼ 63.3%€35k▲ 455%€44k▲ 25.6%€83k▲ 89.5%
Net result€11k-€-7k€109k€122k▲ 12.3%€140k▲ 14.4%
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 89% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.86M
Fixed assets
€1.83M▲ 48.6%
Current assets
€27k▼ 61.1%
Equity and liabilities €1.86M
Equity
€160k▼ 36.5%
Debt
€1.70M▲ 61.9%
The debt ratio rises from 80.6% to 91.4%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€95k▲
2024 · €53k
Cash flow
€151k▲
2024 · €131k
Solvency
8.6%▼
2024 · 19.4%
Current ratio
0.05▼
2024 · 0.35
Quick ratio
0.05▼
2024 · 0.35
Debt / equity
10.62▲
2024 · 4.16
ROE
87.2%▲
2024 · 48.4%
ROA
7.5%▼
2024 · 9.4%
Interest coverage
3.71▼
2024 · 3.74
Debt
€1.70M▲
2024 · €1.05M
Debt ≤ 1 year
€535k▲
2024 · €197k
Debt > 1 year
€1.16M▲
2024 · €850k
Income taxes
€18k▲
2024 · €8k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.30M€1.86M▲
Fixed assets21/28€1.23M€1.83M▲
Tangible fixed assets22/27€325k€331k▲
Land and buildings22€325k€316k▼
Furniture and vehicles24€0€15k▲
Financial fixed assets28€910k€1.50M▲
Current assets29/58€68k€27k▼
Amounts receivable within one year40/41€686€18k▲
Trade receivables40€372€18k▲
Other amounts receivable41€314€25▼
Cash at bank and in hand54/58€66k€7k▼
Deferred charges and accrued income490/1€2k€2k▲
Equity and liabilities
Total equity and liabilities10/49€1.30M€1.86M▲
Equity10/15€252k€160k▼
Contributions10/11€19k€19k=
Reserves13€2k€2k=
Distributable reserves133€2k€2k=
Profit (loss) carried forward14€232k€140k▼
Amounts payable17/49€1.05M€1.70M▲
Amounts payable after more than one year17€850k€1.16M▲
Financial debts170/4€850k€1.16M▲
Amounts payable within one year42/48€197k€535k▲
Current portion of amounts payable after more than one year42€90k€136k▲
Trade debts44€420€5k▲
Suppliers440/4€420€5k▲
Taxes, remuneration and social security45€7k€13k▲
Taxes450/3€7k€13k▲
Other amounts payable47/48€100k€380k▲
Accrued charges and deferred income492/3€4k€5k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€12k▲
Other operating charges640/8€3k€3k▼
Gross operating margin9900€55k€97k▲
Operating profit (loss)9901€44k€83k▲
Financial income75/76B€100k€100k=
Recurring financial income75€100k€100k=
Financial charges65/66B€14k€25k▲
Recurring financial charges65€14k€25k▲
Profit (loss) for the period before taxes9903€130k€158k▲
Income taxes67/77€8k€18k▲
Profit (loss) for the period9904€122k€140k▲
Profit (loss) for the period to be appropriated9905€122k€140k▲
Appropriation of the result
Profit (loss) to be appropriated9906€232k€372k▲
Profit (loss) brought forward from the previous period14P€110k€232k▲
Profit to be distributed694/7€0€232k▲
Return on contributions (dividend)694€0€232k▲
Social balance
Average headcount (FTE)90870.00.0=
The notes to these accounts (18 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2018net €140k ▲14.4%
Operating result €83k, net result €140k, both a record.
11-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Equity above €200kEq €252k ▲93.6%
2 profitable years in a row build equity to €252k.
18-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial
Back to profitnet €109k
Net result €109k after one loss-making year.
31-12
Financial
Equity above €100kEq €130k ▲186%
Equity rises from €46k to €130k.
28-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet €-7k ▼166%
Net result drops to €-7k, the lowest in the series; recovery starts the following year.
20-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
26-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 26 days late
2020
31-12
Financial
Liquidity triplescurrent ratio 10.19
Current ratio from 2.97 to 10.19; short-term debt falls from €29k to €9k.
14-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 45 days late
2019
31-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
02-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
27-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gembloux · 1 establishment unit since 2016
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue du Petit-Leez, Gd-L. 425031 GemblouxGround area
850 m²
Building footprint
125 m²
Parcel 92056E0551/00N000, Wallonia. Linked by address, not a title deed.
1 establishment unit
Rue du Petit-Leez, Gd-L. 42, 5031 Gembloux
since 20162.249.679.626
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92056E0551/00N000 | Wallonia | 850 m² | 1 · 125 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PHAIES
BE 0890.892.243
Ham-sur-Heure-Nalinnes · Eq €160k
APOTHEEK MEES TILDONK
BE 0877.218.510
Haacht · Eq €160k
APOTHEEK GREET VANMEIRHAEGHE ZINGEM
BE 0436.055.283
Kruisem · Eq €160k
La Pharmacie de Saintes
BE 0834.237.315
Tubize · Eq €160k
APOTHEEK HET LAAR
BE 0417.733.765
Beveren-Kruibeke-Zwijndrecht · Eq €161k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,567 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded08-01-2016
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.